Scientific Committee

Randolph Ashton, Ph.D.
Conference Co-Chair
Assistant Professor, Department of Biomedical Engineering
Wisconsin Institute for Discovery, University of Wisconsin–Madison
Randolph S. Ashton received is an an Assistant Professor of Biomedical Engineering in the Wisconsin Institute for Discovery at the University of Wisconsin Madison. The goal of Dr. Ashton’s research is to provide novel regenerative therapies to treat CNS diseases and injury. His lab is currently developing scalable protocols to generate region-specific central nervous system tissues from human pluripotent stem cells (hPSCs). They also meld state of the art biomaterial approaches with hPSC-derived neural stem cells to engineer brain and spinal cord tissue models in vitro. Among his awards and honors, Dr. Ashton was named a 2017 NSF CAREER Awardee, the 2016 Young Faculty Investigator Awardee by the Regenerative Medicine Workshop at Hilton Head, a 2015 Emerging Investigator by Chemical Communications, and a 2013 Rising Star by the Biomedical Engineering Society’s Cellular and Molecular Bioengineering Special Interest Group. Also, he has been awarded a Burroughs Wellcome Fund Innovation in Regulatory Science Award, a Draper Technology Innovation Award from the Wisconsin Alumni Research Foundation, a Basic Research Award from the UW Institute for Clinical & Translational Research. His research is also supported by grants from the NIH, the EPA, and Thermo Fisher Scientific.
William Murphy
William Murphy, Ph.D.
Conference Co-Chair
Harvey D. Spangler Professor, Department of Biomedical Engineering
Wisconsin Institute for Medical Research, University of Wisconsin–Madison
William Murphy, PhD, is a Professor of Biomedical Engineering at the University of Wisconsin Madison. His Bioinspired Materials Lab (BML) is building innovative biomaterials to address significant challenges in biology and medicine. They bring together chemists, biologists, materials scientists, and engineers to create new materials referred to as "bioinspired materials". Our materials are "bioinspired" because they mimic some of the fascinating ways that nature builds materials – from sea shells to human organs. They work closely with biologists to make fundamental scientific discoveries. They also partner with clinicians to create medical devices that can regenerate diseased or damaged tissues. The BML is driven to achieve high impact by pursuing groundbreaking discoveries, translating discoveries into new medical treatments, and training the next generation of leaders in regenerative medicine.
Kaiming Ye
Kaiming Ye, Ph.D.
Program Chair
Professor and Chair, Department of Biomedical Engineering
Binghamton, SUNY
Dr. Kaiming Ye is a professor and chair, Department of Biomedical Engineering, Watson School of Engineering and Applied Science, Binghamton University, SUNY. Before he joined Binghamton University, he was program director for the Biomedical Engineering Program at the National Science Foundation (NSF), managing the biomedical engineering and health science funding program. His research interests focus on stem cell and regenerative medicine and 3D tissue and organ printing. He has published one book, one patent and more than 66 papers in the field. He is best known for his creative work developing 3D scaffolds for directing stem cell pancreatic differentiation, creating fluorescence nanosensors for both in vivo and in vitro continuous glucose monitoring, and formulating recombinant yeast influenza vaccines. His research has been continuously funded by NIH, NSF, JDRF, ABI and industries. He serves as executive/associate editor and editorial board member of 12 journals and has been invited to deliver keynote/plenary speeches at numerous international and national conferences. He has also served on numerous review panels and study sections for NIH and NSF. He is also program evaluator of ABET accreditation for Biomedical Engineering Programs.
The Stem cell and Tissue Engineering Lab focuses on organ and tissue regeneration, 3D tissue and organ printing, biomaterials, nanomedicine, nano-drug delivery, vaccine development, nanosensors, and single molecule imaging and detection. These works in essence address the fundamental biomedical engineering problems of developing new technologies for organ regenerative medicine and new intracellular indicators for studying stem cell differentiation and tissue regeneration/remodeling.
glenn gaudette
Glenn R. Gaudette, Ph.D.
Program Co-Chair
Professor, Department of Biomedical Engineering
Worcester Polytechnic Institute,
Glenn R. Gaudette, PhD, is a Professor of Biomedical Engineering at Worcester Polytechnic Institute. His research, which is supported by the National Institutes of Health and the National Science Foundation, aims to develop a treatment for the millions of Americans suffering from myocardial infarction and other cardiovascular diseases. In May of 2012, he co-founded a company based on some of the pioneering technology developed in his laboratory. Dr. Gaudette also teaches biomedical engineering design and innovation, biomechanics and physiology. He promotes the development of the entrepreneurial mindset in his students through support provided by the Kern Family Foundation.
Roland Kaunas
Roland Kaunas, Ph.D.
Scientific Committee Member
Associate Professor, Department of Biomedical Engineering
Texas A&M University,
Dr. Roland Kaunas is associate professor in the Department of Biomedical Engineering at Texas A&M University. His laboratory focuses on the engineering of micro-tissues containing mesenchymal stem cells as vehicles for regenerating musculoskeletal tissues and as cell-based models for studying bone tumor biology. This work employs sophisticated microfluidic platforms, custom bioreactors, and novel scaffolding strategies involving composites of natural and synthetic polymers.
Dr. Kaunas’ group also studies how mechanical stresses and strains, such as tensile stretch and fluid shear stress, regulate cell function in vascular tissues including arteries, capillaries and lymphatics. This work involves integration of experiments and theory to elucidate the roles of intracellular contractility, applied forces and scaffold material properties on cell architecture and transduction of mechanical stimuli into intracellular signals leading to changes in cell behavior.
Elizabeth Lipke
Elizabeth Lipke, Ph.D.
Scientific Committee Member
Mary and John H. Sanders Endowed Associate Professor, Chemical Engineering
Auburn University,
Dr. Elizabeth Lipke is the Mary and John H. Sanders Associate Professor in the Department of Chemical Engineering at Auburn University. Dr. Lipke completed her graduate studies at Rice University followed by a postdoctoral fellowship at Johns Hopkins University. Dr. Lipke’s research focuses on the use of cell-material interactions to create cellular microenvironments that guide tissue formation and direct cellular function. To support cells in vivo, Dr. Lipke’s research group has established a platform for fabricating injectable, cell-laden hydrogel microspheres and demonstrated successful microsphere-based delivery of autologous endothelial progenitor cells in an equine wound healing model. Dr. Lipke’s group is also investigating novel peptide ligands for capture of endothelial progenitor cells under physiological shear stress. To better understand congenital heart defect formation and advance cardiac regeneration, Dr. Lipke’s research group employs biomimetic materials to direct pluripotent stem cell differentiation and create 3D developing human engineered cardiac tissues; this platform for ontomimetic differentiation has been recently shown to also support in vitro cardiac tissue maturation, including t-tubule formation. For cancer research projects, the Lipke lab has created spheroidal and microfluidic chip-based tissue-engineered tumor models that recapitulate key native tumor characteristics for improved drug testing. In recognition of her research, Dr. Lipke has received several national awards including a National Science Foundation CAREER award, a 3M Nontenured Faculty Award, and an American Heart Association Scientist Development Grant. In addition to the recognition of her research accomplishments, Dr. Lipke has received awards for teaching and mentoring of undergraduate and graduate students.
Krishnendu Roy
Krishnendu Roy, Ph.D.
Scientific Committee Member
Director, Center for ImmunoEngineering
Director, Marcus Center for Cell-Therapy Characterization and Manufacturing (MC3M) Georgia Institute of Technology
Krishnendu Roy, PhD, is the Robert A. Milton Endowed Chair in the Department of Biomedical Engineering at Georgia Institute of Technology. The overall goal of his research is the development of new biomaterial-based strategies for gene/drug delivery and stem cell engineering. Towards this, his laboratory focuses on three major directions: (a) design and development of novel delivery systems for nucleic-acid based immunotherapy and cancer chemotherapy (b) engineering complex microenvironments to study and manipulate stem cells and understand their behavior in biomimetic, three-dimensional conditions and (c) developing novel engineering tools and high throughput methods to generate functional T cells and Dendritic cells from stem cells.